Co-delivery nano-liposome and micro-needle with anti-aging and whitening effects and preparation method of co-delivery nano-liposome and micro-needle
By using nanoliposomes and microneedle technology in skin care products, retinol and nicotinamide are co-transported, which solves the problems of poor retinol stability and poor delivery of nicotinamide, and achieves whitening and anti-aging effects. And environmentally friendly.
Patent Information
- Application Number
- CN202411160178.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-22
- Publication Date
- 2024-11-26
AI Technical Summary
In the prior art, the poor stability of retinol and the poor transdermal delivery effect of nicotinamide limits its application in skin care products, making it difficult to achieve both whitening and anti-aging effects.
Using a co-delivery nanoliposomes and microneedle that combine anti-aging and whitening, the transdermal efficiency of the drug is improved by combining retinol, nicotinamide, lecithin and stabilizer. , nanoliposomes and microneedles with particle sizes ranging from 50 to 500 nm were prepared.
It improves the stability of retinol and the skin retention effect of nicotinamide, enhances its whitening, antioxidant and anti-aging effects, achieves better skin care effects, and simplifies the preparation process and is environmentally friendly.
Smart Images

Figure CN119015138A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of transdermal delivery, and specifically relates to a co-delivery nanoliposome and microneedle having both anti-aging and whitening effects and a preparation method thereof. Background Art
[0002] In recent years, with the booming development of the appearance economy, more and more people have begun to pay attention to the efficacy of cosmetics, and whitening and anti-aging are the two aspects that people pay the most attention to. On the one hand, skin aging is determined by the body's genetic factors. It is a natural process that is difficult to prevent. It manifests as dry skin, loose skin, fine lines, sagging, thinning skin, etc.; on the other hand, it is caused by environmental factors (ultraviolet rays, air pollution, etc.) or lifestyle. Accumulated damage to the skin. On the one hand, as age increases, the body itself ages, the skin function weakens and gradually ages, resulting in local pigmentation causing the skin to darken; on the other hand, exposure to ultraviolet rays can cause skin pigmentation and cause the skin to darken.
[0003] Retinol and its derivatives are anti-aging active ingredients that have received more attention in recent years. They have the effects of promoting cell growth, accelerating cell regeneration, fading fine lines, and anti-oxidation. They are very popular skin care additives in recent years. However, since retinol and its derivatives are fat-soluble vitamins, insoluble in water, extremely sensitive to light, temperature, oxygen, etc., and easily lose their activity, they have disadvantages such as low utilization rate and difficulty in preservation. Products containing retinol need to be designed with special packaging and sealed for storage. In addition, retinol products also have certain skin irritation, and the dosage needs to be gradually increased to build skin tolerance to avoid excessive irritation to the skin. The above shortcomings have led to a certain degree of limitation in their application.
[0004] Niacinamide (NA), also known as nicotinamide and nicotinamide, has always been an evergreen in the whitening industry. It appears as a white crystalline powder, is almost odorless, tastes bitter, is easily soluble in water, ethanol and glycerol, is slightly soluble in ether and chloroform, and has weak hygroscopicity. NA reduces melanin production in the skin by inhibiting the transfer of melanosomes from melanocytes to surrounding keratinocytes. In addition, NA protects the skin from reactive oxygen species and acts as the main barrier of the skin to prevent water loss by enhancing the production of ceramides and fatty acids. NA is a water-soluble compound that does not easily penetrate the stratum corneum into the active epidermis despite its low molecular weight. In addition, niacin, a byproduct in niacinamide, may irritate the skin.
[0005] Therefore, it is necessary to find a method to deliver two skin care active ingredients together to solve the shortcomings of the above two types of active ingredients, promote effective percutaneous absorption, improve stability, and at the same time achieve whitening and anti-aging effects, and give full play to the skin care effect.
[0006] Liposome is a bilayer spherical vesicle composed of amphiphilic phospholipid molecules, with the phospholipid bilayer surrounding the inner water phase. Liposome has the characteristics of biological membranes, so it is also called artificial biological membrane. Liposome is a zwitterionic surfactant with a very wide range of encapsulation, which can encapsulate water-soluble substances, fat-soluble substances and amphoteric substances. Therefore, the characteristics of liposomes can be used to co-encapsulate water-soluble and fat-soluble active ingredients.
[0007] In order to further improve the transdermal effect of drugs, microneedle technology is introduced. Microneedle is a new minimally invasive drug delivery method, generally composed of several to hundreds of microneedles with a tip diameter of less than tens of microns and a needle body length of 25-2000 microns. It can pierce the stratum corneum of the skin to enhance the transdermal effect of drugs. Combining liposomes with microneedle technology can further enhance the transdermal penetration efficiency of retinol and niacinamide, achieving better skin care effects. Summary of the invention
[0008] The purpose of the present invention is to solve the problems of poor stability of retinol and poor transdermal delivery effect of niacinamide in the above-mentioned prior art, and to provide a co-delivery nanoliposome and microneedle with both anti-aging and whitening effects and a preparation method thereof.
[0009] The first aspect of the present invention provides a co-delivery nanoliposome with both anti-aging and whitening effects, the raw materials of which include: retinol or its derivatives, niacinamide, lecithin, a stabilizer, and a solvent for preparing liposomes; the solvent includes a solvent for dissolving retinol or its derivative lecithin, a stabilizer, and a solvent for dissolving niacinamide; the raw materials may also include an antioxidant.
[0010] In a preferred embodiment, the retinol or its derivatives include any one or more combinations of retinol, retinal, retinoic acid, retinol palmitate, hydrogenated retinol, retinol acetate, retinol linoleate, retinol propionate, retinol retinoic acid ester, and hydroxypinacolone retinoic acid ester.
[0011] In a preferred embodiment, the lecithin includes any one or more combinations of soybean lecithin, egg yolk lecithin, hydrogenated soybean lecithin, and hydrogenated egg yolk lecithin.
[0012] In a preferred embodiment, the stabilizer includes any one or more combinations of triglycerides, pyrrolidones, polyglycerol esters, sodium cholate, Tween 80, Tween 20, Tween 60 or cholesterol.
[0013] In a preferred embodiment, the molar ratio of lecithin to stabilizer is 1:(0.001-1), the mass ratio of retinol or its derivative to lecithin is (0.001-0.1):1, and the mass ratio of niacinamide to lecithin is (0.1-4):1.
[0014] In a preferred embodiment, the liposome concentration is 0.1-20 mg / mL.
[0015] In a preferred embodiment, the antioxidant is any one or more combinations of tocopherol, butylated hydroxytoluene, butylated hydroxyanisole, ascorbyl palmitate, and dipotassium glycyrrhizinate.
[0016] In a preferred embodiment, the molar ratio of the antioxidant to lecithin is (0.01-0.1):1.
[0017] In a preferred embodiment, the lecithin is hydrogenated soybean lecithin, the stabilizer is cholesterol, the retinol or its derivative is retinol, the molar ratio of hydrogenated soybean lecithin to cholesterol is 1:0.25, and the mass ratio of retinol to lecithin is 0.075:1.
[0018] In a preferred embodiment, the particle size of the co-delivery nanoliposomes with both anti-aging and whitening properties is 50 to 500 nm, more preferably 100 to 200 nm.
[0019] The second aspect of the present invention provides a method for preparing the above-mentioned co-delivery nanoliposomes with both anti-aging and whitening properties, comprising the following steps:
[0020] (1) Retinol or its derivatives, lecithin, and a stabilizer, or retinol or its derivatives, lecithin, a stabilizer, and an antioxidant are dissolved in an organic solvent to obtain a first mixed solution, and the first mixed solution is then rotary evaporated to obtain a film.
[0021] (2) Dissolving nicotinamide in a buffer solution to obtain a second mixed solution.
[0022] (3) dissolving the film in the second mixed solution, stirring and hydrating to obtain a liposome emulsion.
[0023] (4) Extruding or ultrasonically or high-pressure homogenizing the liposome emulsion to obtain the co-delivery nanoliposome.
[0024] In a preferred embodiment, the organic solvent in step (1) includes one or more of anhydrous ethanol, chloroform, 1,2-propylene glycol, etc. The amount of the organic solvent added is not specifically limited, and should ensure that all the preparation raw materials added in step (1) are completely dissolved.
[0025] In a preferred embodiment, during the rotary evaporation in step (1), the temperature is 20 to 60° C., the vacuum degree is -0.08 to 0.12 MPa, and the time is 30 to 60 minutes.
[0026] In a preferred embodiment, the buffer in step (2) is PBS or HBS, and more preferably HBS. The concentration of nicotinamide in the second mixed solution is preferably 1-50 mg / mL.
[0027] In a preferred embodiment, the stirring temperature in step (3) is controlled at 50-70° C. and the stirring time is 5-60 minutes.
[0028] In a preferred embodiment, in the extrusion treatment in step (4), the treatment method is extrusion through a 100 nm filter membrane, and the number of extrusions is 10 to 60 times.
[0029] In a preferred embodiment, in the ultrasonic treatment in step (4), the ultrasonic power is 120 to 240 W, the pulse mode ultrasound is 5 to 20 seconds, the buffer is 2 to 20 seconds, and the ultrasonic time is 10 to 60 minutes.
[0030] In a preferred embodiment, in the high-pressure homogenization treatment in step (4), the treatment pressure is 100-130 MPa, and the number of cycles is 1-6 times.
[0031] The third aspect of the present invention provides a co-delivery nanoliposome microneedle with both anti-aging and whitening properties, the raw materials of which include the above-mentioned co-delivery nanoliposome with both anti-aging and whitening properties and a microneedle skeleton material.
[0032] In a preferred embodiment, the microneedle skeleton material is chitosan, collagen, gelatin, hyaluronic acid, alginate, pectin, carrageenan, chondroitin, dextran, polylysine, carboxymethyl titin, fibrin, agarose, pullulan and at least one soluble substance of natural origin in cellulose, polyvinyl pyrrolidone, polyethylene glycol, polyvinyl alcohol, sodium carboxymethyl cellulose, polyol, gum arabic, alginate, cyclodextrin, dextrin, glucose, fructose, starch, trehalose, dextrose, maltose, lactose, lactulose, levulose, turanose, raffinose, melezitose, dextran, sorbitol, xylitol, isomalt, polylactic acid, polyglycolic acid, polyethylene oxide, polyacrylic acid, polyacrylamide, polymethacrylic acid and polymaleic acid. At least one biocompatible substance or a mixture of multiple substances; hyaluronic acid is further preferred.
[0033] The fourth aspect of the present invention provides a method for preparing the above-mentioned co-delivery nanoliposome microneedle with both anti-aging and whitening effects, comprising the following steps:
[0034] (1) The microneedle skeleton material is prepared into a solution and mixed with the liposome solution to prepare a microneedle mother solution.
[0035] (2) Add the microneedle mother solution into the microneedle mold, and then evacuate or centrifuge to allow the solution to fill the cavity of the mold.
[0036] (3) placing the filled mold in a dry environment, and demolding it after it dries, thereby obtaining the co-delivery nanoliposome microneedles with both anti-aging and whitening effects.
[0037] In a preferred embodiment, in the microneedle mother solution prepared in step (1), the liposome concentration is 0.1 to 20 mg / mL, and the skeleton material concentration is 25 to 200 mg / mL.
[0038] In a preferred embodiment, the vacuum degree of the vacuum extraction in step (2) is -0.08 to 0.12 MPa, the centrifugal force is 150 to 3000×g, and the centrifugal time is 1 to 30 min.
[0039] The fifth aspect of the present invention provides the use of the above-mentioned co-delivery nanoliposomes or microneedles with both anti-aging and whitening effects in the preparation of products with anti-aging and whitening effects.
[0040] The present invention has the following beneficial effects:
[0041] 1. Simple preparation, no toxic organic solvent residue, environmentally friendly, good stability, and can be produced continuously;
[0042] Second, the prepared co-delivery nanoliposomes have uniform particle size distribution, exhibit non-toxicity to cells, improve the stability of retinol and its derivatives, and enhance the skin retention effect of niacinamide.
[0043] 3. The prepared co-delivery nanolipid microneedles have good mechanical strength, can pierce the skin's stratum corneum, dissolve quickly, allow the active ingredients to quickly enter the active epidermis, and can further enhance the whitening, antioxidant, and anti-aging effects of retinol and niacinamide. BRIEF DESCRIPTION OF THE DRAWINGS
[0044] Figure 1 The melanin content (A) and tyrosinase content (B) tested in Example 1.
[0045] Figure 2 The cell viability (A) and reactive oxygen species content (B) tested in Example 2.
[0046] Figure 3 The particle size stability of the liposomes prepared in Example 3.
[0047] Figure 4 The encapsulation efficiency (A) and drug loading (B) of the nicotinamide liposomes prepared in Example 4 are shown.
[0048] Figure 5 The encapsulation efficiency (A) and drug loading (B) of the retinol liposomes prepared in Example 5 are shown.
[0049] Figure 6 The stability comparison of retinol under different storage conditions in Example 7. Figures A, B, and C are respectively stored in the dark at 4°C, stored in the dark at room temperature, and stored in the light at room temperature.
[0050] Figure 7 These are the test results of the cytotoxicity experiment of the nanoliposomes in Example 8.
[0051] Figure 8 This is a graph showing the liposome uptake in human immortalized epidermal cells in Example 9.
[0052] Fig. 9 The morphology of the nanoliposome microneedles in Example 10. Figure A is a hyaluronic acid co-delivery liposome microneedle RN-Lip-HA MNs, and Figure B is a polyvinyl alcohol co-delivery liposome microneedle RN-Lip-PVA MNs.
[0053] Fig.10 The dissolution diagrams of the nanoliposome microneedles in Example 11. Figure A shows hyaluronic acid co-delivered liposome microneedles RN-Lip-HA MNs, and Figure B shows polyvinyl alcohol co-delivered liposome microneedles RN-Lip-PVA MNs.
[0054] Fig.11 The mechanical properties test results of the nanoliposome microneedles in Example 12 and the trypan blue solution staining of mouse skin. Figure A shows the mechanical properties test results of the two microneedles, and Figures B and C are the trypan blue solution staining of hyaluronic acid co-delivered liposome microneedles RN-Lip-HA MNs and polyvinyl alcohol co-delivered liposome microneedles RN-Lip-PVA MNs inserted into mouse skin.
[0055] Fig.12 The transdermal release curve (A) and skin retention amount (B) of retinol in Example 13.
[0056] Fig.13 The transdermal release curve (A) and skin retention amount (B) of niacinamide in Example 13.
[0057] Fig.14 These are the melanin content (A) and tyrosinase content (B) in Example 14.
[0058] Fig.15 The cell viability (A) and reactive oxygen species content (B) tested in Example 15 are shown.
[0059] Fig.16 This is a graph showing the test results of the type I collagen content in Example 16. DETAILED DESCRIPTION
[0060] The present invention is further described below with reference to examples, but the embodiments of the present invention are not limited thereto.
[0061] Example 1: Evaluation of the whitening effect of the combination of retinol and niacinamide
[0062] (1) Melanin content test
[0063] B16F10 cells were plated at 2 × 10 5 The cells were seeded in a 24-well plate at a density of . After incubation for 1 day, the cells were treated with DMEM containing 0.55 mg / mL nicotinamide (NA), 3 μg / mL retinol (RET), and the same concentration of nicotinamide retinol mixed solution (RN) and 100 nmol / L α-MSH, and incubated for 48 hours. The cells treated with DMEM containing only α-MSH were used as the model group, and the cells with only replacement of the culture medium were used as the control. The old culture medium was discarded, washed with PBS, and the cells were lysed with 2 mol / L sodium hydroxide, incubated in a water bath at 80°C for 2 hours, and centrifuged. The absorbance of the supernatant was detected (495 nm wavelength), and a blank group was set up to subtract the background effect. The relative amount of melanin production was calculated, and the results are shown in Figure 1 A.
[0064] from Figure 1 A shows that both retinol and niacinamide can reduce the amount of melanin produced in B16F10 cells, and the combination of the two can further reduce the amount of melanin produced. Compared with niacinamide and retinol solutions, the mixed solution has an effect of inhibiting melanin by 1.2 times and 1.15 times, respectively.
[0065] (2) Tyrosinase content test
[0066] B16F10 cells were plated at 1×10 5 The cells were seeded in a 24-well plate at a density of . After incubation for 1 day, the cells were treated with DMEM containing 0.55 mg / mL nicotinamide (NA), 3 μg / mL retinol (RET), and the same concentration of nicotinamide retinol mixed solution (RN) and 100 nmol / L α-MSH, respectively, and incubated for 48 hours. The cells treated with DMEM containing only α-MSH were used as the model group, and the cells only replaced with the culture medium were used as the control. The old culture medium was discarded, 1% (V%) TritonX-100 was added to lyse the cells, and the well plate was placed in a -80℃ refrigerator to accelerate lysis and rewarmed after 1 hour. After centrifugation, the supernatant was mixed with 0.1% (W / V) L-dopa solution in a ratio of 1:1, reacted at room temperature for 2 hours, a blank group was set up to deduct the background effect, and the absorbance at a wavelength of 495 nm was detected. The relative amount of tyrosinase generated was calculated, and the results are shown in Figure 1 B.
[0067] from Figure 1B shows that both retinol and nicotinamide can reduce the production of tyrosinase in B16F10 cells, and the combination of the two can further reduce the production of tyrosinase. Compared with nicotinamide and retinol solutions, the mixed solution has an inhibitory effect on tyrosinase of 1.15 times and 1.3 times, respectively.
[0068] Example 2: Evaluation of the antioxidant effect of retinol and niacinamide combined
[0069] (1) Protective effect on H2O2-induced oxidative damage model of HaCaT cells
[0070] HaCaT cells were cultured at 1×10 4 The cells were inoculated into 96-well plates at a density of 100 cells / well. After 1 day of adaptive culture, the old culture medium was discarded and complete culture medium containing 800μM H2O2 and 0.55mg / mL nicotinamide (NA) or 3μg / mL retinol (RET) or a mixed solution of nicotinamide and retinol (RN) of the same concentration was added and cultured for 24h. The blank control group only replaced the fresh culture medium without any treatment, and the injury model group only added 800μM H2O2. The cell survival rate was detected by MTT method. The cell survival rate of each group was calculated according to the absorbance. The results are shown in Figure 2 A.
[0071] As can be seen from the figure, compared with the niacinamide or retinol solution group, the mixed solution increased the cell survival rate by 1.4 times and 1.2 times, respectively.
[0072] (2) ROS level detection
[0073] HaCaT cells were plated at 1 × 10 5 The cells were inoculated into 24-well plates at a density of 10 cells / mL and allowed to adhere to the wall for 24 hours. The old culture medium was removed and complete culture medium containing 800 μM H2O2 and 0.55 mg / mL nicotinamide (NA) or 3 μg / mL retinol (RET) or a mixed solution of nicotinamide and retinol (RN) of the same concentration was added and incubated for 24 hours. HaCaT cells treated with DMEM were used as the control group, and HaCaT cells treated with DMEM containing 800 μM H2O2 for 24 hours were used as the model group. After incubation, the old culture medium was discarded, the cells were washed three times with PBS, and DMEM containing 20 μM DCFH-DA was added to continue incubation for 1 hour. The cells were washed with PBS, lysed with 1% Triton X-100, centrifuged, and the fluorescence intensity was detected at a wavelength of 495 nm using an ELISA reader to indicate the level of reactive oxygen in each group.
[0074] from Figure 2As can be seen in B, the level of reactive oxygen species in cells treated with the mixed solution decreased by 1.2 times and 1.15 times compared with the niacinamide or retinol treatment groups, respectively.
[0075] Example 3: Preparation of blank liposomes and study of particle size stability
[0076] Liposomes were prepared by thin film hydration extrusion method. Hydrogenated soybean lecithin and cholesterol were dissolved in chloroform at fixed molar ratios of 1:0.25 (①), 1:0.5 (②), and 1:1 (③) (i.e. ①: 22.18 mg hydrogenated soybean lecithin, 2.82 mg cholesterol; ②: 19.94 mg hydrogenated soybean lecithin, 5.06 mg cholesterol; ③: 16.58 mg hydrogenated soybean lecithin, 8.42 mg cholesterol). The chloroform was removed by evaporation under reduced pressure to obtain a uniform lipid film. The obtained lipid film was dissolved in 5 mL HBS buffer and stirred and hydrated at 55°C for 1 hour. After hydration, it was repeatedly extruded through a 100 nm PC membrane 25 times to reduce the liposome particle size. The liposome sample was filtered through a 0.22 μm filter and stored at 4°C. The particle size and PDI of the liposomes obtained at different molar ratios of hydrogenated soybean lecithin and cholesterol are shown in Table 1, and the particle size change under room temperature conditions is shown in Table 1. Figure 3 .
[0077] Table 1 shows the particle size and PDI of blank liposomes with different formulations
[0078]
[0079] Prescription ② showed flocculent precipitation on day 15. Figure 3 It can be found that the particle size stability of prescriptions ① and ③ is good within five months, and the particle size remains within 200nm after five months.
[0080] Example 4: Preparation of Nicotinamide Liposomes (NA-Lip) and Encapsulation Efficiency Test
[0081] (1) Preparation of Nicotinamide Liposomes with Different Formulas
[0082] Nicotinamide liposomes were prepared using the two prescriptions ① and ③ in Example 3. Hydrogenated soybean lecithin and cholesterol were weighed and dissolved in chloroform at a fixed molar ratio of 1:0.25 (①) and 1:1 (③), and the chloroform was removed by evaporation under reduced pressure to obtain a uniform lipid film. A 100 mg / mL nicotinamide (NA) solution mother solution prepared with HBS was diluted to 2 and 10 mg / mL. The obtained lipid film was dissolved in 5 mL of the nicotinamide dilution solution and stirred and hydrated at 55°C for 30 minutes. The obtained crude liposome suspension was repeatedly extruded 25 times through a 100 nm PC membrane to reduce and stabilize the liposome particle size.
[0083] (2) Nicotinamide encapsulation efficiency and drug loading test
[0084] The encapsulation rate and drug loading of nicotinamide were tested by ultrafiltration centrifugation. The test results of the encapsulation rate and drug loading of nicotinamide are shown in Figure 4 ,from Figure 4 It can be seen that the nicotinamide liposomes prepared according to prescription ① showed better effects than prescription ③ in terms of encapsulation efficiency and drug loading of two concentrations of nicotinamide. Figure 4 The nicotinamide hydration concentration during liposome encapsulation was 2 mg / mL. Figure 4 The nicotinamide hydration concentration during liposome encapsulation was 10 mg / mL.
[0085] Example 5: Preparation of retinol liposomes (RET-Lip) and encapsulation efficiency and drug loading test
[0086] (1) Preparation of retinol liposomes with different formulations
[0087] Retinol liposomes were prepared using the two prescriptions ① and ③ in Example 1. Hydrogenated soybean lecithin and cholesterol were weighed and dissolved in chloroform at a fixed molar ratio of 1:0.25 (①) and 1:1 (③), and retinol was added to the above chloroform (the amount of retinol added was a mass ratio of retinol to hydrogenated soybean lecithin of 0.05:1 and 0.075:1), and the chloroform was removed by reduced pressure evaporation to obtain a uniform lipid film. The obtained lipid film was dissolved in 5 mL of HBS buffer and stirred and hydrated at 55 ° C for 30 min. The obtained crude liposome suspension was repeatedly extruded 25 times through a 100 nm PC membrane to reduce and stabilize the liposome particle size.
[0088] (2) Retinol encapsulation efficiency and drug loading test
[0089] The content of retinol was tested by antimony trichloride colorimetry. The results of the retinol encapsulation efficiency and drug loading test are shown in Figure 5 ,from Figure 5 It can be seen that the retinol liposomes prepared according to prescription ① showed better effects than prescription ③ in terms of encapsulation efficiency and drug loading of two concentrations of retinol. Figure 5 The mass ratio of retinol to hydrogenated soybean lecithin when encapsulated in liposome A is 0.05:1. Figure 5 The mass ratio of retinol to hydrogenated soybean lecithin when encapsulated in B liposomes was 0.075:1.
[0090] Example 6: Preparation of retinol and nicotinamide co-delivery liposomes (RN-Lip) and encapsulation efficiency and drug loading test
[0091] Retinol liposomes were prepared using the two prescriptions ① and ③ in Example 1. Hydrogenated soybean lecithin and cholesterol were weighed and dissolved in chloroform at a fixed molar ratio of 1:0.25 (①) and 1:1 (③), and retinol was added to the above chloroform (the amount of retinol added was a mass ratio of retinol to hydrogenated soybean lecithin of 0.075:1), and the organic reagent was removed by reduced pressure evaporation to obtain a uniform lipid film. The obtained lipid film was dissolved in 5mL of HBS buffer containing 10mg / mL nicotinamide and stirred and hydrated at 55°C for 30min. The obtained crude liposome suspension was repeatedly extruded 25 times through a 100nm PC membrane to reduce and stabilize the liposome particle size. Table 2 shows the encapsulation efficiency and drug loading of retinol and nicotinamide in the co-delivery liposomes prepared by the two prescriptions ① and ③.
[0092] Table 2
[0093]
[0094] It can be seen from Table 2 that prescription ① is better than prescription ③ in terms of encapsulation of niacinamide and retinol. The liposomes used in the following examples are all prepared by prescription ①.
[0095] Example 7: Evaluation of Retinol Stability
[0096] The retinol content was tested by antimony trichloride colorimetry.
[0097] Test 1: Take the co-delivery liposomes (RN-Lip) prepared in Example 6, the retinol liposomes (RET-Lip) prepared in Example 5, and the retinol solution (50% ethanol aqueous solution) (Free RET), adjust the retinol in the three groups to the same concentration (40 μg / mL), store them at 4°C in the dark, and test the remaining retinol content of the three groups at regular intervals. The results are shown in Table 1. Figure 6 A.
[0098] Test 2: Take the co-delivery liposomes prepared in Example 6, the retinol liposomes prepared in Example 5, and the retinol solution (50% ethanol aqueous solution), adjust the retinol in the three groups to the same concentration (40 μg / mL), store them at room temperature and avoid light, and test the remaining retinol content of the three groups at regular intervals. The results are shown in Table 2. Figure 6 B.
[0099] Test 3: Take the co-delivery liposomes prepared in Example 6, the retinol liposomes prepared in Example 5, and the retinol solution (50% ethanol aqueous solution), adjust the retinol in the three groups to the same concentration (40 μg / mL), store them in the room temperature environment and exposed to light, and test the remaining retinol content of the three groups at regular intervals. The results are shown in Figure 6 C.
[0100] from Figure 6 It can be seen that under the three storage conditions, the remaining amount of retinol in the co-delivery liposomes is higher than that in the other two groups. Therefore, the prepared co-delivery liposomes enhance the stability of retinol.
[0101] Example 8: Toxicity test of nanoliposomes on human immortalized epidermal cells
[0102] Taking the survival rate of human immortalized epidermal cells (HaCaT) as an indicator, the cell safety of the co-delivery nanoliposomes prepared in Example 6 at different concentrations (concentrations of 0.1 μg / mL, 1 μg / mL, 10 μg / mL, 100 μg / mL, 1000 μg / mL, and 2500 μg / mL) was tested. The control group did not add the nanoparticles. The results are shown in Figure 7 ,from Figure 7 It can be seen that the co-delivery nanoliposomes prepared by the present invention exhibit non-cytotoxicity.
[0103] Example 9: Study on the cell uptake capacity of free drugs and drug-loaded liposomes using human immortalized epidermal cells HaCaT cells were treated with RhoB solution and RhoB-loaded liposomes (Lip-RhoB) prepared by replacing the nicotinamide solution with the RhoB solution according to Example 4 for 2 hours and 4 hours, respectively, with a final RhoB concentration of 20 μg / mL. The cell uptake was observed by laser confocal microscopy, and the results are shown in Figure 8 .from Figure 8 The fluorescence of RhoB can be seen in the fluorescence photography of Lip-RhoB at 2 hours and 4 hours, and the fluorescence intensity of Lip-RhoB group is higher than that of Free RhoB group, and the fluorescence intensity of Lip-RhoB group has increased significantly with the increase of time. The above results show that compared with Free RhoB group, Lip-RhoB group significantly promotes HaCaT cells to take up nanoliposome-encapsulated RhoB.
[0104] Example 10: Preparation of co-delivery nanoliposome microneedles
[0105] Step S1, accurately weigh 2.15 g of hyaluronic acid (45 kDa) or polyvinyl alcohol (15 kDa, degree of alcoholysis: 87.0-89.0 (mol / mol)) and dissolve it in 10 mL of deionized water, and mix the liposome solution with the hyaluronic acid solution or polyvinyl alcohol solution in a volume ratio of 3:7 to prepare a microneedle mother solution.
[0106] Step S2, 350 μL of microneedle mother solution was added to the mold, and after centrifugation, the mold was placed in a dry and dark place to dry. After drying, the mold was demoulded to obtain nanoliposome microneedles (RN-Lip-HA MNs or RN-Lip-PVA MNs). Fig. 9 .
[0107] pass Fig. 9 A and B show that the entire array of two types of co-delivery nanoliposome microneedles have intact needle tips.
[0108] Example 11: Testing the Dissolution Ability of Co-delivered Nanoliposome Microneedles
[0109] Take the two microneedles prepared in Example 10, insert the microneedles vertically into the mouse skin, press gently, remove the microneedles after 30s and 120s, respectively, and photograph the microneedle tip morphology under an inverted light microscope. Fig.10 .pass Fig.10 A and B show that the tips of the two prepared co-delivery nanoliposome microneedles were completely dissolved at 120 s, indicating that both types of microneedles have good dissolution ability.
[0110] Example 12: Mechanical strength and skin ability test of microneedles
[0111] The mechanical properties of 20 needles of the nanoliposome microneedle patch were tested using a universal tensile testing machine, and the average mechanical strength of each needle was calculated. The results are shown in Fig.11 A. From Fig.11 It can be seen from A that both nanoliposome microneedles have good mechanical strength.
[0112] The prepared microneedles were vertically inserted into the mouse skin and held for 2 minutes. The microneedles were removed and the skin morphology was observed under an optical electron microscope after staining with trypan blue solution. Fig.11 B, C. From Fig.11 It can be seen from B and C that both microneedles can pierce the stratum corneum of the skin.
[0113] Example 13: In vitro transdermal experiment of co-delivery of nanoliposome microneedles
[0114] The retinol content was detected by HPLC. The test method was as follows: the mobile phase consisted of acetonitrile and water in a ratio of 80:20 (v / v), the flow rate was 1.0 mL / min, the temperature was 25°C, the sample injection volume was 10 μL, retinol was detected at a wavelength of 325 nm, and the total analysis time was 15 min.
[0115] The content of nicotinamide was detected by UV spectrophotometer.
[0116] In vitro transdermal experiments were performed using a TP-6 transdermal diffusion instrument to investigate and compare the transdermal effects of the nicotinamide liposomes (NA-Lip) prepared in Example 4, the co-delivery liposomes (RN-Lip) prepared in Example 6, the two nanoliposome microneedles (RN-Lip-PVA MNs / RN-Lip-HA MNs) prepared in Example 10, and a nicotinamide solution of equal concentration (Free NA), wherein the concentration of nicotinamide was 8 mg / mL, as well as the transdermal effects of the retinol liposomes (RET-Lip) prepared in Example 5, the co-delivery liposomes (RN-Lip) prepared in Example 6, the two nanoliposome microneedles (RN-Lip-PVA MNs / RN-Lip-HA MNs) prepared in Example 10, and a retinol solution of equal concentration (Free RET), wherein the concentration of retinol was 40 μg / mL. 1 mL of sample solution was added to the supply chamber or the microneedle was inserted into the mouse skin, and 7.5 mL of HBS at pH 7.4 was added to the receiving cell as the receiving medium. The cumulative permeation of the characteristic drug in the receiving medium was calculated at different test times. The experiment was terminated after 48 hours, and the skin homogenate supernatant was tested and analyzed to calculate the skin retention of the specific drug.
[0117] The transdermal release curves and skin retention of retinol and niacinamide are shown in Fig.12 , Fig.13 .
[0118] from Fig.12 As can be seen from A, the retinol transdermal release of the co-delivery liposome microneedle group was significantly higher than that of the retinol solution group. At 48 hours, the transdermal delivery effects of the two co-delivery liposome microneedle groups were similar, and the retinol transdermal release of the co-delivery liposome group, retinol liposome group, and retinol solution group increased by 1.5 times, 1.4 times, and 2.6 times, respectively. Fig.12 It can be seen from B that the skin retention effects of retinol in the two co-delivery liposome microneedles are basically the same, which are 1.2 times, 1.5 times and 1.8 times of the co-delivery liposome, retinol liposome and retinol solution, respectively. Therefore, the co-delivery liposome microneedle enhances the transdermal release efficiency of retinol and increases the retention amount of retinol in the skin.
[0119] from Fig.13 As can be seen from A, the transdermal release of nicotinamide in the co-delivery liposome microneedle group was significantly higher than that in the nicotinamide solution group. At 48 hours, the transdermal release effects of the two co-delivery liposome microneedles were similar, and the transdermal release of nicotinamide increased by 1.15 times, 1.3 times, and 2.5 times compared with the co-delivery liposome group, nicotinamide liposome group, and nicotinamide solution group, respectively. Fig.13In B, it can be seen that the skin retention effects of niacinamide in the two co-delivery liposome microneedle groups are basically the same, which are 1.15 times, 1.3 times and 4.3 times that of the co-delivery liposome, niacinamide liposome and niacinamide solution. Therefore, the co-delivery liposome microneedle enhances the transdermal efficiency of niacinamide and greatly enhances the retention of niacinamide in the skin.
[0120] Example 14: Evaluation of the whitening effect of co-delivery of nanoliposome microneedles
[0121] (1) Melanin content test
[0122] B16F10 cells were plated at 2 × 10 5 The cells were seeded in a 24-well plate at a density of . After incubation for 1 day, the cells were treated with a mixed solution (RN) containing 0.55 mg / mL niacinamide and 3 μg / mL retinol, or co-delivery liposomes (RN-Lip) containing the same concentration of active ingredients, or co-delivery liposome microneedle dissolution solution (RN-Lip-PVA MNs / RN-Lip-HAMNs) containing the same concentration of active ingredients, or hyaluronic acid solution (HA) or polyvinyl alcohol solution (PVA) and DMEM containing 100 nmol / L α-MSH, and incubated for 48 hours. Cells treated with DMEM containing only α-MSH were used as the model group, and cells only replaced with culture medium were used as the control. The old culture medium was discarded, washed with PBS, and the cells were lysed with 2 mol / L sodium hydroxide, incubated in a water bath at 80°C for 2 hours, and centrifuged. The absorbance of the supernatant was detected (495 nm wavelength), and a blank group was set up to subtract the background effect. The relative amount of melanin production was calculated, and the results are shown in Fig.14 .
[0123] from Fig.14 As can be seen from A, the melanin content in B16F10 cells in the RN-Lip-HA MNs group was reduced by 1.4 times, 1.4 times and 2.1 times compared with the RN-Lip-PVA MNs group, RN-Lip group and RN group, respectively, while there was no significant difference between the RN-Lip-PVA MNs group and the RN-Lip group. The above results indicate that microneedle delivery co-delivery liposomes prepared using HA can significantly reduce the melanin content in cells.
[0124] (2) Tyrosinase content test
[0125] B16F10 cells were plated at 1×10 5The cells were seeded in 24-well plates at a density of 100 cells / mL. After one day of incubation, the cells were treated with a mixed solution (RN) containing 0.55 mg / mL nicotinamide and 3 μg / mL retinol, or co-delivery liposomes (RN-Lip) containing the same concentration of active ingredients, or co-delivery liposome microneedle dissolution solutions (RN-Lip-PVA MNs / RN-Lip-HA MNs) containing the same concentration of active ingredients, or hyaluronic acid solution (HA) or polyvinyl alcohol solution (PVA) and DMEM containing 100 nmol / L α-MSH, and incubated for 48 hours. The cells treated with DMEM containing only α-MSH were used as the model group, and the cells treated with only replacement of the culture medium were used as the control. The old culture medium was discarded, 1% (V%) TritonX-100 was added to lyse the cells, and the well plate was placed in a -80℃ refrigerator to accelerate lysis, and rewarmed after 1 hour. After centrifugation, the supernatant was mixed with 0.1% (w / v) L-dopa solution at a ratio of 1:1, and reacted at room temperature for 2 hours. A blank group was set to deduct the background effect, and the absorbance at a wavelength of 495 nm was detected to calculate the amount of tyrosinase generated.
[0126] from Fig.14 As can be seen from B, the tyrosinase content in B16F10 cells in the RN-Lip-HA MNs group was reduced by 1.7 times, 1.7 times and 2.1 times compared with the RN-Lip-PVA MNs group, RN-Lip group and RN group, respectively, while there was no significant difference between the RN-Lip-PVA MNs group and the RN-Lip group. The above results indicate that microneedle delivery co-delivery liposomes prepared using HA can significantly reduce the tyrosinase content in cells.
[0127] Example 15: Evaluation of the Antioxidant Effect of Co-delivery Nanoliposome Microneedles
[0128] (1) Protective effect on H2O2-induced oxidative damage model of HaCaT cells
[0129] HaCaT cells were cultured at 1×10 4 The cells were inoculated into 96-well plates at a density of 100 / well. After 1 day of adaptive culture, the old culture medium was discarded and a mixed solution (RN) containing 800μM H2O2 and 0.55mg / mL nicotinamide and 3μg / mL retinol or a co-delivery liposome (RN-Lip) containing the same concentration of active ingredients or a co-delivery liposome microneedle dissolution solution (RN-Lip-PVA MNs / RN-Lip-HA MNs) or a hyaluronic acid solution (HA) or a polyvinyl alcohol solution (PVA) in a complete culture medium were added and cultured for 24 hours. The blank control group only replaced the fresh culture medium without any treatment, and the injury model group only added 800μM H2O2. The cell survival rate was detected by MTT method. The cell survival rate of each group was calculated according to the absorbance. The results are shown in the table. Fig.15 A.
[0130] from Fig.15 As can be seen from A, compared with the RN-Lip-PVA MNs group, RN-Lip group and RN group, the RN-Lip-HA MNs group increased the cell survival rate by 1.45 times, 1.5 times and 1.7 times, respectively, while the cell survival rate of the RN-Lip-PVA MNs group was increased by 1.06 times and 1.2 times compared with the RN-Lip group and RN group, respectively, indicating that the use of HA to prepare microneedle delivery co-delivery liposomes can significantly improve the survival rate of cells after oxygen damage, while the use of PVA to prepare microneedle delivery co-delivery liposomes did not significantly improve the survival rate of cells.
[0131] (2) ROS level detection
[0132] HaCaT cells were plated at 1 × 10 5 The cells were inoculated into a 24-well plate at a density of 10 cells, and the cells were allowed to adhere to the wall and grow for 24 hours. The old culture medium was removed, and a mixed solution (RN) containing 800μM H2O2 and 0.55mg / mL nicotinamide and 3μg / mL retinol or a co-delivery liposome (RN-Lip) containing the same concentration of active ingredients or a co-delivery liposome microneedle dissolution solution (RN-Lip-PVA MNs / RN-Lip-HA MNs) or a hyaluronic acid solution (HA) or a polyvinyl alcohol solution (PVA) was added and cultured for 24 hours. HaCaT cells treated with DMEM were used as the control group, and HaCaT cells treated with DMEM containing 800μM H2O2 for 24 hours were used as the model group. After incubation, the old culture medium was discarded, washed 3 times with PBS, and DMEM containing 20μM DCFH-DA was added to continue incubation for 1 hour. The cells were washed with PBS, lysed with 1% Triton X-100, centrifuged, and the fluorescence intensity was detected using an ELISA reader.
[0133] from Fig.15 As can be seen from B, the level of reactive oxygen species in cells treated with RN-Lip-HA MNs decreased by 1.2 times, 1.25 times and 1.4 times compared with the RN-Lip-PVA MNs group, RN-Lip group and RN group, respectively, while the level of reactive oxygen species in cells of the RN-Lip-PVAMNs group decreased by 1.05 times and 1.17 times compared with the RN-Lip group and RN group, respectively, indicating that the co-delivery liposome microneedles prepared with HA have the best effect in reducing cellular reactive oxygen species, which is better than the co-delivery liposome microneedles prepared with PVA.
[0134] Example 16: Anti-aging effect of co-delivery of liposome microneedles
[0135] A sufficient concentration of human fibroblasts (BJ cells) were seeded into a 24-well plate. After incubation for 1 day, they were co-cultured with a mixed solution (RN) containing 0.55 mg / mL niacinamide and 3 μg / mL retinol, or co-delivery liposomes (RN-Lip) containing the same concentration of active ingredients, or co-delivery liposome microneedle dissolution solution (RN-Lip-PVA MNs / RN-Lip-HA MNs) containing the same concentration of active ingredients, or hyaluronic acid solution (HA) or polyvinyl alcohol solution (PVA) in complete culture medium for 24 hours. During the experiment, the concentration of retinol was 3 μg / mL. BJ cells treated with DMEM alone were used as the control group. After 48 hours, the culture medium was collected, and the content of type I collagen in the culture supernatant was detected using an ELISA kit. The results are shown in Table 1. Fig.16 .
[0136] Fig.16 It is a test of the content of type I collagen. It can be seen from the figure that the production of type I collagen in the RN-Lip-HA MNs group increased by 12 times compared with the blank group, and increased by 1.42 times and 1.4 times compared with the RN-Lip group and RN-Lip-PVA MNs group, respectively, while there was no significant difference between the RN-Lip-PVA MNs group and the RN-Lip group, indicating that the use of HA to prepare microneedle delivery co-delivery liposomes can significantly enhance the production of collagen.
[0137] The above embodiments are only used to help explain the present invention and are not used to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A co-delivery nanoliposome with both anti-aging and whitening properties, characterized in that: The raw materials include: retinol or its derivative, niacinamide, lecithin, a stabilizer, and a solvent for preparing liposomes; the solvent includes a solvent for dissolving retinol or its derivative lecithin, a stabilizer, and a solvent for dissolving niacinamide; Or the raw materials include: retinol or its derivatives, niacinamide, lecithin, a stabilizer, an antioxidant, and a solvent for preparing liposomes.
2. The co-delivery nanoliposome according to claim 1, characterized in that: The retinol or its derivatives include any one or more combinations of retinol, retinal, retinoic acid, retinol palmitate, hydrogenated retinol, retinol acetate, retinol linoleate, retinol propionate, retinol retinoic acid ester, and hydroxypinacolone retinoic acid ester; The lecithin includes any one or more combinations of soybean lecithin, egg yolk lecithin, hydrogenated soybean lecithin, and hydrogenated egg yolk lecithin; The stabilizer includes any one or more combinations of triglycerides, pyrrolidones, polyglycerol esters, sodium cholate, Tween 80, Tween 20, Tween 60 or cholesterol.
3. The co-delivery nanoliposome according to claim 1, characterized in that: The lecithin is hydrogenated soybean lecithin, the stabilizer is cholesterol, and the molar ratio of hydrogenated soybean lecithin to cholesterol is 1:0.
25.
4. The co-delivery nanoliposome according to claim 1, characterized in that: The particle size is 50~500nm.
5. The method for preparing the co-delivery nanoliposome according to any one of claims 1 to 4, characterized in that: The steps include: (1) dissolving retinol or its derivatives, lecithin, and a stabilizer, or retinol or its derivatives, lecithin, a stabilizer, and an antioxidant in an organic solvent to obtain a first mixed solution, and then rotary evaporating the first mixed solution to obtain a film; (2) dissolving nicotinamide in a buffer solution to obtain a second mixed solution; (3) dissolving the film in the second mixed solution and stirring to obtain a liposome emulsion; (4) Extruding or ultrasonically or high-pressure homogenizing the liposome emulsion to obtain the co-delivery nanoliposome.
6. A co-delivery nanoliposome microneedle with both anti-aging and whitening properties, characterized in that: The raw materials include the co-delivery nanoliposome and microneedle skeleton material described in any one of claims 1-4.
7. The co-delivery nanoliposome microneedle with both anti-aging and whitening properties according to claim 6, characterized in that: The microneedle skeleton material comprises a mixture of at least one or more of chitosan, collagen, gelatin, hyaluronic acid, alginate, pectin, carrageenan, chondroitin, dextran, polylysine, carboxymethyl titin, fibrin, agarose, pullulan, cellulose, polyvinyl pyrrolidone, polyethylene glycol, polyvinyl alcohol, sodium carboxymethyl cellulose, polyols, gum arabic, alginate, cyclodextrin, dextrin, glucose, fructose, starch, trehalose, dextrose, maltose, lactose, lactulose, levulose, turanose, raffinose, melezitose, dextran, sorbitol, xylitol, isomalt, polylactic acid, polyglycolic acid, polyethylene oxide, polyacrylic acid, polyacrylamide, polymethacrylic acid, and polymaleic acid.
8. The co-delivery nanoliposome microneedle with both anti-aging and whitening properties according to claim 6, characterized in that: The microneedle skeleton material is hyaluronic acid.
9. The method for preparing the co-delivery nanoliposome microneedle with both anti-aging and whitening properties according to any one of claims 6 to 8, characterized in that: The steps include: (1) preparing a solution of a microneedle skeleton material and mixing it with a liposome solution to prepare a microneedle mother solution; (2) adding the microneedle master solution into the microneedle mold so that the solution fills the cavity of the mold; (3) The mold filled with the microneedle mother solution is dried and then demoulded to obtain the co-delivery nanoliposome microneedle.
10. Use of the co-delivery nanoliposomes according to any one of claims 1 to 4 or the microneedles according to any one of claims 6 to 8 in the preparation of products with anti-aging and whitening effects.
Citation Information
Cited By
Plant seed oil composition as well as preparation method and application thereof
CN121370696A
